Patent · US Active

1′-cyano nucleoside analogs and methods for treatment of viral infections

US11851438B2 · kind B2 · utility

6Cited by

91References

16Claims

0Family size

Assignee

Gilead Sciences, Inc. · US

Inventors

Mark J. Bartlett · Castro Valley, US
Daniel H. Byun · Foster City, US
Yifan Deng · Milpitas, US
Jennifer L. Cosman Ellis · Foster City, US
Rao V. Kalla · Cupertino, US
Richard L. Mackman · Millbrae, US
Dustin Siegel · Redwood City, US
Xianhuang Zeng · Redwood City, US

Key dates

Filing date	Mar 6, 2023
Grant date	Dec 26, 2023
Priority date	—
Expiry date	Mar 6, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/6561
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

1′-Cyano nucleoside analogs of Formula I and methods of using said compounds, singly or in combination with additional agents, and salts or pharmaceutical compositions of said compounds for the treatment of viral infections are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.